Nynne Nyboe Andersen, MD

Nynne Nyboe Andersen
PhD student
Statens Serum Institut
5 Artillerivej , 206/204
DK-2300 Copenhagen S
+45 3268 3268


Nynne Nyboe Andersen is as of 1st of June 2012 employed by the Department of Epidemiology Research with the primary objective to conduct a Ph.D thesis within the field of Gastroenterology. Nynne Nyboe Andersen is educated as a medical doctor in January 2011 from the University of Copenhagen.

Research area

Gatroenterology, epidemiological research.

Is presently conducting the PhD study 'Safety of Anti-Tumor Necrosis Factor - alpha Treatment - A nationwide Cohort Study'.

Selected publications

  • Andersen NN Safety of Anti-Tumour Necrosis Factor-Alpha Treatment - A Nationwide Cohort Study. University of Copenhagen. 2016; Februar,
  • Andersen NN, Gørtz S, Frisch M, Jess T Reduced risk of UC in families affected by appendicitis: a Danish national cohort study. Gut.2016; gutjnl-2015-311131. doi: 10.1136/gutjnl-2015-311131,
  • Andersen NN, Pasternak B, Friis-Møller N, Andersson M, Jess T Association between tumor necrosis factor-alpha inhibitors and risk of serious infections in people with inflammatory bowel disease: nationwide Danish cohort study. BMJ.2015; 350, h2809
  • Rungoe C, Andersen NN, Jess T Inflammatory bowel disease and risk of coronary heart disease. Trends Cardiovasc Med.2015; 25(8), 699-704
  • Aalykke C, Jensen MD, Fallingborg J, Jess T, Langholz E, Meisner S, Andersen NN, Riis LB, Thomsen OØ, Tøttrup A Colonoscopy surveillance for dysplasia and colorectal cancer in patients with inflammatory bowel disease. Dan Med J.2015; 62, B4995